SUPN
NASDAQ · Pharmaceuticals
Supernus Pharmaceuticals Inc
$45.14
+0.66 (+1.48%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-11.92%
1Y
+44.49%
YTD
-8.75%
Open$44.55
Previous Close$44.48
Day High$45.50
Day Low$44.12
52W High$59.68
52W Low$30.83
Volume—
Avg Volume635.1K
Market Cap2.58B
P/E Ratio—
EPS$-0.51
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$49.76
Below
SMA 200
$43.00
Above
RSI (14)
59.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+101.2% upside
Current
$45.14
$45.14
Target
$90.83
$90.83
$64.19
$90.83 avg
$118.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 739.18M | 721.01M | 1.12B |
| Net Income | -39,635,328 | -34,794,962 | 218.96M |
| Profit Margin | -5.4% | -5.1% | 19.5% |
| EBITDA | 27.94M | 25.89M | 345.29M |
| Free Cash Flow | — | — | 147.80M |
| Rev Growth | +2.5% | +2.5% | +10.9% |
| Debt/Equity | — | — | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |